ClinicalTrials.gov
public full text
Public Domain
Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS)
Irritable bowel syndrome patients will be given either placebo pill or no treatment for a period of 3 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome#1031830
- Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome#901110
- Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists#880652
- A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis#858029
- A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome#268138
Record · ID 872382
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive